John Chung MD, Richard Cormack MD, Roshni Patel MBBS, Avnesh Thakor MD, PhD, Darren Klass MD, PhD, David Liu MD
{"title":"Surefire抗反流装置在脾次全栓塞术中的新应用","authors":"John Chung MD, Richard Cormack MD, Roshni Patel MBBS, Avnesh Thakor MD, PhD, Darren Klass MD, PhD, David Liu MD","doi":"10.1016/j.jvsc.2015.07.005","DOIUrl":null,"url":null,"abstract":"<div><p>An unstable patient presented with an enlarging splenic hematoma, for whom splenectomy was contraindicated. The decision was made to treat this patient with subtotal splenic embolization. Initial attempts at embolotherapy using a conventional end-hole catheter resulted in a false angiographic end point with reflux into short gastric arteries, likely due to splenic parenchymal pressurization from the hematoma. The Surefire antireflux device (Surefire Medical Inc, Westminster, Colo) was therefore employed. The Surefire device allowed successful subtotal splenic embolization. Whereas it is currently primarily used in hepatic interventional oncology, we have shown that it can be successfully used in other settings to increase embolization efficiency while mitigating nontargeted embolization.</p></div>","PeriodicalId":91348,"journal":{"name":"Journal of vascular surgery cases","volume":"1 4","pages":"Pages 242-245"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jvsc.2015.07.005","citationCount":"1","resultStr":"{\"title\":\"Novel use of the Surefire antireflux device in subtotal splenic embolization\",\"authors\":\"John Chung MD, Richard Cormack MD, Roshni Patel MBBS, Avnesh Thakor MD, PhD, Darren Klass MD, PhD, David Liu MD\",\"doi\":\"10.1016/j.jvsc.2015.07.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>An unstable patient presented with an enlarging splenic hematoma, for whom splenectomy was contraindicated. The decision was made to treat this patient with subtotal splenic embolization. Initial attempts at embolotherapy using a conventional end-hole catheter resulted in a false angiographic end point with reflux into short gastric arteries, likely due to splenic parenchymal pressurization from the hematoma. The Surefire antireflux device (Surefire Medical Inc, Westminster, Colo) was therefore employed. The Surefire device allowed successful subtotal splenic embolization. Whereas it is currently primarily used in hepatic interventional oncology, we have shown that it can be successfully used in other settings to increase embolization efficiency while mitigating nontargeted embolization.</p></div>\",\"PeriodicalId\":91348,\"journal\":{\"name\":\"Journal of vascular surgery cases\",\"volume\":\"1 4\",\"pages\":\"Pages 242-245\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jvsc.2015.07.005\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of vascular surgery cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2352667X15000971\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of vascular surgery cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352667X15000971","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
一个不稳定的病人表现为脾血肿扩大,脾切除术是禁忌。我们决定用脾次全栓塞治疗该患者。最初尝试使用传统的端孔导管进行栓塞治疗,结果导致血管造影终点错误,回流到胃短动脉,可能是由于血肿造成的脾实质加压。因此采用Surefire抗反流装置(Surefire Medical Inc, Westminster, Colo)。Surefire装置允许成功的脾次全栓塞。虽然目前它主要用于肝脏介入肿瘤学,但我们已经证明它可以成功地用于其他环境,以提高栓塞效率,同时减轻非靶向栓塞。
Novel use of the Surefire antireflux device in subtotal splenic embolization
An unstable patient presented with an enlarging splenic hematoma, for whom splenectomy was contraindicated. The decision was made to treat this patient with subtotal splenic embolization. Initial attempts at embolotherapy using a conventional end-hole catheter resulted in a false angiographic end point with reflux into short gastric arteries, likely due to splenic parenchymal pressurization from the hematoma. The Surefire antireflux device (Surefire Medical Inc, Westminster, Colo) was therefore employed. The Surefire device allowed successful subtotal splenic embolization. Whereas it is currently primarily used in hepatic interventional oncology, we have shown that it can be successfully used in other settings to increase embolization efficiency while mitigating nontargeted embolization.